317 related articles for article (PubMed ID: 1341991)
21. [Antipsychotic-induced symptomatic hyperprolactinemia: clinical consequences and therapeutic strategies].
Pollice R; Di Giovambattista E; Tomassini A; Di Pucchio A; Ussorio D; Roncone R; Casacchia M
Clin Ter; 2007; 158(2):173-9. PubMed ID: 17566521
[TBL] [Abstract][Full Text] [Related]
22. Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences.
Maguire GA
J Clin Psychiatry; 2002; 63 Suppl 4():56-62. PubMed ID: 11913677
[TBL] [Abstract][Full Text] [Related]
23. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic evaluation of hyperprolactinemia.
Biller BM
J Reprod Med; 1999 Dec; 44(12 Suppl):1095-9. PubMed ID: 10649817
[TBL] [Abstract][Full Text] [Related]
25. Hyperprolactinemia-related adverse events associated with antipsychotic treatment in children and adolescents.
Jerrell JM; Bacon J; Burgis JT; Menon S
J Adolesc Health; 2009 Jul; 45(1):70-6. PubMed ID: 19541252
[TBL] [Abstract][Full Text] [Related]
26. Clinical presentation of hyperprolactinemia.
Luciano AA
J Reprod Med; 1999 Dec; 44(12 Suppl):1085-90. PubMed ID: 10649815
[TBL] [Abstract][Full Text] [Related]
27. Reversal of hypogonadotropic hypogonadism with tamoxifen in a patient with hyperprolactinemia resistant to dopamine agonists.
López JM; Oestreicher E
Fertil Steril; 2005 Sep; 84(3):756. PubMed ID: 16169415
[TBL] [Abstract][Full Text] [Related]
28. [Dopaminergic agents in the treatment of hyperprolactinemia].
Mornex R; Hugues B
J Pharmacol; 1983; 14 Suppl 3():81-103. PubMed ID: 6369001
[TBL] [Abstract][Full Text] [Related]
29. Drug Insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia?
Goffin V; Touraine P; Culler MD; Kelly PA
Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):571-81. PubMed ID: 17024156
[TBL] [Abstract][Full Text] [Related]
30. Attenuation of antipsychotic-induced hyperprolactinemia with clozapine.
Bunker MT; Marken PA; Schneiderhan ME; Ruehter VL
J Child Adolesc Psychopharmacol; 1997; 7(1):65-9. PubMed ID: 9192542
[TBL] [Abstract][Full Text] [Related]
31. A case of sibutramine-induced hyperprolactinemia.
Soares Leaes CG; Pereira-Lima JF; da Costa Oliveira M
Neuro Endocrinol Lett; 2011; 32(5):616-8. PubMed ID: 22167128
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological hyperprolactinemia: a retrospective analysis of 501 hyperprolactinemia cases in primary care setting.
García Cano AM; Rosillo M; Gómez Lozano A; Jiménez Mendiguchía L; Marchán Pinedo M; Rodríguez Torres A; Araujo-Castro M
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3239-3246. PubMed ID: 37910184
[TBL] [Abstract][Full Text] [Related]
33. Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia.
Poyraz BC; Aksoy C; Balcioğlu I
Eur Neuropsychopharmacol; 2008 Sep; 18(9):667-72. PubMed ID: 18539008
[TBL] [Abstract][Full Text] [Related]
34. Effects of antipsychotics on sexual and endocrine function in women: implications for clinical practice.
Smith S
J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S27-32. PubMed ID: 12832947
[TBL] [Abstract][Full Text] [Related]
35. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
36. Idiopathic hyperprolactinemia in a 15-year-old boy: a case report and literature review.
Jaruratanasirikul S; Janejindamai S
J Med Assoc Thai; 1995 Jul; 78(7):388-92. PubMed ID: 7658185
[TBL] [Abstract][Full Text] [Related]
37. Immunoreactive prolactin in breast milk and plasma of women with hyperprolactinemia, galactorrhea and menstrual dysfunction.
Yuen BH
Int J Fertil; 1986; 31(1):67-70. PubMed ID: 2908279
[TBL] [Abstract][Full Text] [Related]
38. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
39. Amisulpride-induced hyperprolactinemia is reversible following discontinuation.
Paparrigopoulos T; Liappas J; Tzavellas E; Mourikis I; Soldatos C
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):92-6. PubMed ID: 16938372
[TBL] [Abstract][Full Text] [Related]
40. Not only dopamine D2 receptors involved in Peony-Glycyrrhiza Decoction, an herbal preparation against antipsychotic-associated hyperprolactinemia.
Wang D; Wong HK; Zhang L; McAlonan GM; Wang XM; Sze SC; Feng YB; Zhang ZJ
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):332-8. PubMed ID: 22796279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
